Notes to Condensed Consolidated Financial
Statements
(unaudited)
|
1.
|
DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION
|
TheStreet, Inc. is
a
leading financial news and information provider. Our content and products provide individual investors with actionable information
from the worlds of finance and business. The Company’s flagship brand, The Street (
www.thestreet.com
)
has produced unbiased business news and market analysis for individual investors for more than 20 years.
From time to time, the Board
of Directors and our senior management team review and evaluate strategic opportunities and alternatives as part of a
long-term strategy to increase stockholder value. Following the realignment of our capital structure in November 2017, the
Board focused on a review of the Company’s diverse businesses and in June 2018 sold its RateWatch business for $33.5
million to S&P Global. The Company most recently sold its business-to-business, or B2B, units, The Deal and BoardEx, for
$87.3 million to Euromoney Institutional Investor PLC, which closed in February 2019 (the “B2B Sale”). As a
result of these dispositions, these business units have been reported as discontinued operations in our Condensed
Consolidated Statements of Operations, and the related assets and liabilities have been presented as discontinued operations
in the Condensed Consolidated Balance Sheets.
Following the
B2B Sale, we continue to own and operate our business-to-consumer, or B2C, business, which is led by our namesake website,
TheStreet.com
,
and includes our free editorial content and houses our premium subscription products that target varying segments of the retail
investing public. Our remaining business primarily generates revenue from premium subscription products, advertising and event
revenue. We will continue to execute on our business plan for the B2C business, while also considering all potential strategic
options with respect to the remaining business. We intend to continuously review our expenses and remove costs where appropriate.
On April 3, 2019, the Company
announced that its Board of Directors had declared a special cash distribution in the amount of approximately $94.3 million
or $17.70 per share ($1.77 per share prior to the reverse stock split discussed below), paid on April 22, 2019 to stockholders
of record on April 15, 2019. In connection with the distribution, the Board of Directors also approved a 10-for-1 reverse
stock split of the Company’s common stock effective prior to the opening of trading on April 26, 2019. All share
amounts and per share amounts within this Form 10-QT have been adjusted for this stock split. Additionally, the Company
changed its fiscal and tax year to a March 31 year-end. As such, the Company’s next fiscal year will run from April 1,
2019 through March 31, 2020. As a result of the change in fiscal year-end, this document reflects the Company’s
Transition Report on Form 10-QT for the period from January 1, 2019 through March 31, 2019.
Unaudited Interim Financial
Statements
The interim condensed consolidated
balance sheet as of March 31, 2019, the condensed consolidated statements of operations, comprehensive income (loss) and
statements of stockholders’ equity for the three months ended March 31, 2019 and 2018, and the condensed statements of
cash flows for the three months ended March 31, 2019 and 2018 are unaudited. The unaudited interim financial statements have
been prepared on a basis consistent with the Company’s annual financial statements and, in the opinion of management,
reflect all adjustments, which include only normal recurring adjustments necessary to state fairly the Company’s
financial position as of March 31, 2019, its results of consolidated operations and comprehensive income (loss) for the three
months ended March 31, 2019 and 2018, and cash flows for the three months ended March 31, 2019 and 2018. The financial data
and other financial information disclosed in the notes to the financial statements related to these periods are also
unaudited. The results of operations for the three months ended March 31, 2019 are not necessarily indicative of the results
to be expected for the fiscal year ending March 31, 2020 or for any other future annual or interim period.
There have been no material changes in
the significant accounting policies from those that were disclosed in the Company’s Annual Report on Form 10-K for the
fiscal year ended December 31, 2018, which was initially filed with the SEC on March 15, 2019 and subsequently amended on
March 21, 2019 solely to correct certain clerical errors and on April 30, 2019 solely to include the information required by
Part III of Form 10-K, other than the adoption of ASU 2016-02 “Leases” on January 1, 2019. These financial
statements should also be read in conjunction with the audited consolidated financial statements and notes thereto for the
year ended December 31, 2018. Certain information and note disclosures normally included in the financial statements prepared
in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have
been omitted pursuant to such rules and regulations. The consolidated balance sheet as of December 31, 2018 included herein
was derived from the audited financial statements as of that date but does not include all disclosures required by GAAP.
The Company has evaluated subsequent events
for recognition or disclosure.
Recently Issued Accounting Pronouncements
On January 1, 2019, we adopted ASU No.
2016-02,
Leases
(“ASU 2016-02”). ASU 2016-02 establishes a right-of-use (“ROU”) model that
requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12
months. The most significant effects relate to the recognition of new ROU assets and lease liabilities on our balance sheet
for our real estate operating leases and providing significant new disclosures about our leasing activities. The
Company’s financial position for reporting periods beginning on or after January 1, 2019 are presented under the new
guidance, while prior periods are not adjusted and continue to be reported in accordance with previous guidance as provided
for in the alternative transition approach under ASU No. 2018-11, “Leases (Topic 842): Targeted Improvements. Upon
adoption on January 1, 2019, we recognized lease liabilities of approximately $5.1 million, of which $1.7 million was held
for sale, with corresponding ROU assets of $4.2 million, of which $1.6 million was held
for sale, based on the present value of the remaining minimum rental payments
under current leasing standards for existing operating leases. The difference between the lease liability and ROU asset
upon adoption is attributable to the offset of existing deferred rent liability against the ROU asset.
In June 2016, the FASB issued ASU No. 2016-13,
“Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments
” (“ASU
2016-13”). ASU 2016-13 requires the measurement and recognition of expected credit losses for financial assets held at amortized
cost. ASU 2016-13 is effective for interim and annual reporting periods beginning after December 15, 2019, with early adoption
permitted for interim and annual reporting periods beginning after December 15, 2018. ASU 2016-13 is required to be adopted
using the modified retrospective basis, with a cumulative-effect adjustment to retained earnings as of the beginning of the first
reporting period in which the guidance is effective. Based upon the level and makeup of the Company’s financial receivables,
past loss activity and current known activity regarding our outstanding receivables, the Company does not expect that the adoption
of this new standard will have a material impact on its consolidated financial statements.
Sale of RateWatch
On June 20, 2018, the Company entered
into an asset purchase agreement (the “Purchase Agreement”) with S&P Global Market Intelligence Inc., an
affiliate of S&P Global Inc.(“S&P”), pursuant to which the Company agreed to sell the assets comprising
its RateWatch business to S&P for an aggregate consideration of $33.5 million in cash. Of the purchase price, $3,350,000 was placed in escrow to secure S&P’s rights to indemnification and their right to any
post-closing adjustment in its favor. This escrow amount is included within other receivables on the Company’s balance sheet.
Operating results for the RateWatch business,
which have been previously included in the Business to Business Segment, have now been reclassified as discontinued operations
for all periods presented.
Gain on the sale of RateWatch amounted
to $23.6 million, net of a tax expense of $4.9 million, was calculated as the selling price less direct costs to complete the
transaction. Included in such costs is approximately $568 thousand pertaining to certain employee costs that were
assumed by the Company as part of the transaction.
The following table presents the
discontinued operations of RateWatch in the March 31, 2018 Condensed Consolidated Statement of Operations. These amounts
exclude previously allocated corporate overhead costs.
|
|
Three Months
|
|
|
|
Ended
|
|
|
|
March 31, 2018
|
|
Net revenue
|
|
$
|
2,133,684
|
|
Operating expense:
|
|
|
|
|
Cost of services
|
|
|
455,731
|
|
Sales and marketing
|
|
|
331,692
|
|
General and administrative
|
|
|
161,855
|
|
Depreciation and amortization
|
|
|
87,073
|
|
Total operating expense
|
|
|
1,036,351
|
|
Operating income
|
|
$
|
1,097,333
|
|
Income tax expense
|
|
|
(328,263
|
)
|
Net income
|
|
|
769,070
|
|
The following table presents the discontinued
operations of RateWatch in the March 31, 2018 Condensed Consolidated Statements of Cash Flows:
|
|
Three Months Ended
|
|
|
|
March 31, 2018
|
|
Net cash provided by operating activities
|
|
$
|
1,448,343
|
|
Net cash used in investing activities
|
|
|
(4,339
|
)
|
Net increase in cash, cash equivalents and restricted cash
|
|
$
|
1,444,004
|
|
Sale of B2B Business
On February 14, 2019, TheStreet sold
its B2B business to Euromoney Institutional Investor PLC for $87.3 million. As part of the sale, a portion of the proceeds
amounting to $620 thousand was placed in escrow and the Company recognized approximately $3.3 million in deal related costs,
of which $2.3 million was paid during the period ended March 31, 2019. The decision to sell the B2B business was part of the
Board’s continuous review of strategic alternatives to enhance shareholder value.
Operating results for the B2B
business have now been reclassified as discontinued operations for all periods presented.
The following table
presents the discontinued operations of our B2B business in the Consolidated Balance Sheets:
ASSETS
|
|
December 31, 2018
|
|
Current Assets:
|
|
|
|
|
Accounts receivable, net
|
|
$
|
2,585,227
|
|
Other receivables, net
|
|
|
42,344
|
|
Prepaid expenses and other current assets
|
|
|
555,084
|
|
Total Current Assets
|
|
|
3,182,655
|
|
Noncurrent Assets:
|
|
|
|
|
Property and equipment, net
|
|
|
561,593
|
|
Other assets
|
|
|
1,132,992
|
|
Goodwill
|
|
|
2,016,417
|
|
Other intangibles, net
|
|
|
9,423,005
|
|
Deferred tax asset
|
|
|
1,634,222
|
|
Total Assets
|
|
$
|
17,950,884
|
|
|
|
|
|
|
LIABILITIES
|
|
|
|
|
Current Liabilities:
|
|
|
|
|
Accounts payable
|
|
$
|
446,237
|
|
Accrued expenses
|
|
|
1,287,970
|
|
Deferred revenue
|
|
|
11,440,212
|
|
Other current liabilities
|
|
|
43,220
|
|
Total Current Liabilities
|
|
|
13,217,639
|
|
Noncurrent Liabilities:
|
|
|
|
|
Other liabilities
|
|
|
209,498
|
|
Total Liabilities
|
|
$
|
13,427,137
|
|
|
|
|
|
|
The following table
presents the discontinued operations of our B2B business in the Consolidated Statement of Operations:
|
|
For the Three Months Ended
|
|
|
|
March 31, 2019
|
|
|
March 31, 2018
|
|
Net revenue
|
|
$
|
3,015,023
|
|
|
$
|
5,903,940
|
|
Operating expense:
|
|
|
|
|
|
|
|
|
Cost of services
|
|
|
1,113,850
|
|
|
|
1,871,231
|
|
Sales and marketing
|
|
|
786,069
|
|
|
|
1,435,432
|
|
General and administrative
|
|
|
417,374
|
|
|
|
886,991
|
|
Depreciation and amortization
|
|
|
351,405
|
|
|
|
667,350
|
|
Acceleration of equity awards
|
|
|
321,584
|
|
|
|
—
|
|
Total operating expense
|
|
|
2,990,282
|
|
|
|
4,861,004
|
|
Operating income
|
|
|
24,741
|
|
|
|
1,042,936
|
|
Interest income
|
|
|
768
|
|
|
|
1,861
|
|
Provision for income taxes
|
|
|
(7,053
|
)
|
|
|
(312,547
|
)
|
Net income
|
|
$
|
18,456
|
|
|
$
|
732,250
|
|
The following table
presents the discontinued operations of our B2B business in the Consolidated Statements of Cash Flows:
|
|
For the Three Months Ended
|
|
|
|
March 31, 2019
|
|
|
March 31, 2018
|
|
Net cash provided by operating activities
|
|
$
|
696,075
|
|
|
$
|
1,717,215
|
|
Net cash used in investing activities
|
|
|
(247,483
|
)
|
|
|
(469,355
|
)
|
Net increase in cash, cash equivalents and restricted cash
|
|
$
|
448,592
|
|
|
$
|
1,247,860
|
|
Adoption of ASC Topic 606, “Revenue from Contracts
with Customers”
On January 1, 2018, we adopted Topic 606
using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for
reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and
continue to be reported in accordance with our historic accounting under Topic 605.
The Company recorded an adjustment to opening
accumulated deficit of approximately $774 thousand due to the cumulative impact of adopting Topic 606, with the impact primarily
related to sales commissions.
Nature of our Services
Our current business consists of
consumer subscription revenue primarily comprised of subscriptions that provide access to securities investment information
and stock market commentary. The consumer business also generated advertising revenue which is comprised of fees charged for
the placement of advertising and sponsorships, primarily within
TheStreet.com
website. Other revenue from the consumer
business is primarily composed of events/conferences, information services and other miscellaneous revenue. Prior to the sale
of The Deal and BoardEx, our business-to-business operations generated subscription revenue primarily comprised of
subscriptions that provide access to director and officer profiles, relationship capital management services and
transactional information pertaining to the mergers and acquisitions environment.
We provide subscription and advertising services
on a global basis to a broad range of clients. Our principal source of revenue is derived from fees for subscription services sold on an annual or monthly basis. We measure revenue based upon the consideration specified in the client arrangement, and
revenue is recognized when the performance obligations in the client arrangement are satisfied. A performance obligation is a promise
in a contract to transfer a distinct service to the customer. The transaction price of a contract is allocated to each distinct
performance obligation and recognized as revenue when or as, the customer receives the benefit of the performance obligation. Clients
typically receive the benefit of our services as they are performed. Under ASC 606, revenue is recognized when a customer obtains
control of promised services in an amount that reflects the consideration we expect to receive in exchange for those services.
To achieve this core principal, the Company applies the following five steps:
|
1)
|
Identify the contract with a customer
|
A contract with a customer exists when (i)
the Company enters into an enforceable contract with a customer that defines each party’s rights regarding the services to
be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance and, (iii)
the Company determines that collection of substantially all consideration for services that are transferred is probable based on
the customer’s intent and ability to pay the promised consideration. The Company applies judgment in determining the customer’s
ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience
or, in the case of a new customer, published credit and financial information pertaining to the customer.
|
2)
|
Identify the performance obligations in the contract
|
Performance obligations promised in a
contract are identified based on the services that will be transferred to the customer that are both capable of being
distinct, whereby the customer can benefit from the service either on its own or together with other resources that are
readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the
transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes
multiple promised services, the Company must apply its judgment to determine whether promised services are capable of being
distinct in the context of the contract. If these criteria are not met, the promised services are accounted for as a combined
performance obligation.
|
3)
|
Determine the transaction price
|
The transaction price is determined based
on the consideration to which the Company will be entitled in exchange for transferring services to the customer.
|
4)
|
Allocate the transaction price to performance obligations
in the contract
|
If the contract contains a single
performance obligation, the entire transaction price is allocated to the single performance obligation. However, if a series
of distinct services that are substantially the same qualifies as a single performance obligation in a contract with variable
consideration, the Company must determine if the variable consideration is attributable to the entire contract or to a
specific part of the contract. Contracts that contain multiple performance obligations require an allocation of the
transaction price to each performance obligation based on a relative standalone selling price basis unless the transaction
price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct service that
forms part of a single performance obligation. The Company determines standalone selling price based on the price at which
the performance obligation is sold separately. If the standalone selling price is not observable through past transactions,
the Company estimates the standalone selling price by taking into account available information such as market conditions and
internally approved pricing guidelines related to the performance obligations.
|
5)
|
Recognize revenue when or as the Company satisfies
a performance obligation
|
The Company satisfies performance obligations
either over time or at a point in time. Revenue is recognized at the time the related performance obligation is satisfied by transferring
a promised service to a customer.
Substantially all of our revenue is recognized
over time as the services are performed. For subscriptions, revenue is recognized ratably over the subscription period. For advertising,
revenue is recognized as the advertisement is displayed, provided that collection of the resulting receivable is reasonably assured.
The following table presents our revenues
disaggregated by revenue discipline.
|
|
For the Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2019
|
|
|
2018
|
|
Subscription
|
|
$
|
4,942,736
|
|
|
$
|
4,675,258
|
|
Advertising
|
|
|
1,548,315
|
|
|
|
1,699,592
|
|
Other
|
|
|
197,934
|
|
|
|
296,353
|
|
Total Revenue
|
|
$
|
6,688,985
|
|
|
$
|
6,671,203
|
|
Deferred Revenues
We record deferred revenues when cash payments
are received in advance of our performance, primarily for subscription revenues. The increase in deferred revenues for the three
months ended March 31, 2019 is primarily driven by cash payments received in advance of satisfying our performance obligations.
Practical Expedients and Exemptions
The Company did not apply any practical expedients
during the adoption of ASC 606. The Company elected to use the portfolio method in the calculation of the deferred contract costs.
|
4.
|
CASH AND CASH EQUIVALENTS,
MARKETABLE SECURITIES AND RESTRICTED CASH
|
The Company’s cash and cash equivalents
and restricted cash primarily consist of checking accounts and money market funds. As of March 31, 2019 and December 31, 2018,
marketable securities consist of two municipal auction rate securities (“ARS”) issued by the District of Columbia with
a cost basis of approximately $1.9 million and a fair value of approximately $1.9 million. With
the exception of the ARS, Company policy limits the maximum maturity for any investment to three years. The ARS mature in the year
2038. The Company accounts for its marketable securities in accordance with the provisions of ASC 320-10. The Company classifies
these securities as available for sale and the securities are reported at fair value. The securities are currently valued at their
full purchase price. If there were any unrealized gains or losses, they would be recorded as a component of accumulated other comprehensive
gain (loss) and excluded from net income as they are deemed temporary. Additionally, as of March 31, 2019 and December 31, 2018,
the Company has a total of $500 thousand of cash that serves as collateral for an outstanding letter of credit, and which cash
is therefore restricted. The letter of credit serves as a security deposit for the Company’s office space in New York City.
|
|
March
31,
2019
|
|
|
December
31,
2018
|
|
Cash and cash equivalents
|
|
$
|
117,991,200
|
|
|
$
|
37,029,262
|
|
Marketable securities
|
|
|
1,850,000
|
|
|
|
1,850,000
|
|
Restricted cash
|
|
|
500,000
|
|
|
|
500,000
|
|
Total cash and cash equivalents, marketable securities and restricted cash
|
|
$
|
120,341,200
|
|
|
$
|
39,379,262
|
|
On February 14, 2019, the Company
sold its B2B business to Euromoney Institutional Investor PLC for $87.3 million, contributing to the difference in cash and
cash equivalents as of March 31, 2019 compared to December 31, 2018.
On April 22, 2019, the Company made a
special cash distribution of approximately $94.3 million, or $17.70 per share ($1.77 per share prior to the 10-for-1 reverse
stock split effected on April 26, 2019), to stockholders of record on April 15, 2019.
5.
|
FAIR VALUE MEASUREMENTS
|
The Company measures the fair value of its
financial instruments in accordance with ASC 820-10, which refines the definition of fair value, provides a framework for measuring
fair value and expands disclosures about fair value measurements. ASC 820-10 defines fair value as the price that would be received
to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting
date. The statement establishes consistency and comparability by providing a fair value hierarchy that prioritizes the inputs to
valuation techniques into three broad levels which are described below:
|
●
|
Level 1: Inputs are quoted
market prices in active markets for identical assets or liabilities (these are observable market inputs).
|
|
●
|
Level 2: Inputs other than
quoted market prices included within Level 1 that are observable for the asset or liability (includes quoted market prices for
similar assets or identical or similar assets in markets in which there are few transactions, prices that are not current or vary
substantially).
|
|
●
|
Level 3: Inputs are unobservable
inputs that reflect the entity’s own assumptions in pricing the asset or liability (used when little or no market data is
available).
|
Financial assets and liabilities included
in our financial statements and measured at fair value are classified based on the valuation technique level in the table below:
|
|
As of March 31, 2019
|
|
Description:
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
Cash and cash equivalents (1)
|
|
$
|
117,991,200
|
|
|
$
|
117,991,200
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Restricted cash (1)
|
|
|
500,000
|
|
|
|
500,000
|
|
|
|
—
|
|
|
|
—
|
|
Marketable securities (2)
|
|
|
1,850,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,850,000
|
|
Total at fair value
|
|
$
|
120,341,200
|
|
|
$
|
118,491,200
|
|
|
$
|
—
|
|
|
$
|
1,850,000
|
|
|
|
As of December 31, 2018
|
|
Description:
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
Cash and cash equivalents (1)
|
|
$
|
37,029,262
|
|
|
$
|
37,029,262
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Restricted cash (1)
|
|
|
500,000
|
|
|
|
500,000
|
|
|
|
—
|
|
|
|
—
|
|
Marketable securities (2)
|
|
|
1,850,000
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,850,000
|
|
Total at fair value
|
|
$
|
39,379,262
|
|
|
$
|
37,529,262
|
|
|
$
|
—
|
|
|
$
|
1,850,000
|
|
|
(1)
|
Cash, cash equivalents
and restricted cash, totaling approximately $118.5 million and $37.5 million as of March 31, 2019 and December 31, 2018, respectively,
consist primarily of checking accounts and money market funds for which we determine fair value through quoted market prices.
|
|
(2)
|
Marketable securities include
two municipal ARS issued by the District of Columbia having a fair value totaling approximately $1.9 million as of March 31, 2019
and December 31, 2018. Historically, the fair value of ARS investments approximated par value due to the frequent resets through
the auction process. Due to events in credit markets, the auction events, which historically have provided liquidity for these
securities, have been unsuccessful. The result of a failed auction is that these ARS holdings will continue to pay interest in
accordance with their terms at each respective auction date; however, liquidity of the securities will be limited until there
is a successful auction, the issuer redeems the securities, the securities mature or until such time as other markets for these
ARS holdings develop. For each of our ARS, we evaluate the risks related to the structure, collateral and liquidity of the investment,
and forecast the probability of issuer default, auction failure and a successful auction at par, or a redemption at par, for each
future auction period. Temporary impairment charges are recorded in accumulated other comprehensive loss, whereas other-than-temporary
impairment charges are recorded in our consolidated statement of operations. As of March 31, 2019, the Company determined
there was no decline in the fair value of its ARS investments from its cost basis.
|
The following tables provide a reconciliation
of the beginning and ending balance for the Company’s assets and liabilities measured at fair value using significant unobservable
inputs (Level 3):
|
|
Marketable Securities
|
|
Balance December 31, 2018
|
|
$
|
1,850,000
|
|
Change in fair value of investment
|
|
|
—
|
|
Balance March 31, 2019
|
|
$
|
1,850,000
|
|
|
6.
|
STOCK-BASED COMPENSATION
|
We account for stock-based compensation in
accordance with ASC 718-10,
Share Based Payment Transactions
(“ASC 718-10”). This requires that the cost resulting
from all share-based payment transactions be recognized in the financial statements based upon estimated fair values.
Stock-based compensation expense recognized
in the Company’s consolidated statements of operations for the three months ended March 31, 2019 and 2018 includes compensation
expense for all share-based payment awards based upon the estimated grant date fair value. The Company recognizes compensation
expense for share-based payment awards on a straight-line basis over the requisite service period of the award. As stock-based
compensation expense recognized in the periods ended March 31, 2019 and 2018 is based upon awards ultimately expected to vest,
it has been reduced for estimated forfeitures. The Company estimates forfeitures at the time of grant which are revised, if necessary,
in subsequent periods if actual forfeitures differ from those estimates.
The Company estimates the value of stock
option awards on the date of grant using the Black-Scholes option-pricing model. This determination is affected by the Company’s
stock price as well as assumptions regarding expected volatility, risk-free interest rate, and expected dividends. Because option-pricing
models require the use of subjective assumptions, changes in these assumptions can materially affect the fair value of the options.
The assumptions presented in the table below represent the weighted-average value of the applicable assumption used to value stock
option awards at their grant date. In determining the volatility assumption, the Company used a historical analysis of the volatility
of the Company’s share price for the preceding period equal to the expected option lives. The expected option lives, which
represent the period of time that options granted are expected to be outstanding, were estimated based upon the “simplified”
method for “plain-vanilla” options. The risk-free interest rate assumption was based upon observed interest rates appropriate
for the term of the Company’s stock option awards. The dividend yield assumption was based on the history and expectation
of future dividend payouts. The value of the portion of the award that is ultimately expected to vest is recognized as expense
over the requisite service period. The Company’s estimate of pre-vesting forfeitures is primarily based on historical experience
and is adjusted to reflect actual forfeitures as the options vest.
There were no options granted during the
three months ended March 31, 2019. The weighted-average grant date fair value per share of stock option awards granted during the
three months ended March 31, 2018 was $4.90 using the Black-Scholes model with the following weighted-average assumptions:
Expected option lives
|
|
3.5 years
|
|
Expected volatility
|
|
|
42.67
|
%
|
Risk-free interest rate
|
|
|
2.05
|
%
|
Expected dividend yield
|
|
|
0.00
|
%
|
The value of each restricted stock unit awarded
is equal to the closing price per share of the Company’s Common Stock on the date of grant. The value of the portion of the
award that is ultimately expected to vest is recognized as expense over the requisite service periods. There were no restricted
stock units awarded during the three months ended March 31, 2019. The weighted-average grant date fair value per share of restricted
stock units granted during the three months ended March 31, 2018 was $14.70.
At the Company’s May 2018 Board meeting,
the number of shares available for grant was increased by 520 thousand shares.
With the sale of our B2B business, the
Company’s Board of Directors accelerated the vesting of all outstanding stock options and restricted stock units as of
the closing of the sale, or February 14, 2019, under a change of control clause.
As of March 31, 2019, there
remained approximately 340 thousand shares available for future awards under the Company’s 2007 Performance Incentive
Plan (the “2007 Plan”). In connection with awards under both the 2007 Plan and awards issued outside of the 2007
Plan as inducement grants to new hires, the Company recorded approximately $3.7 million and $340 thousand of stock-based
compensation for the three-month periods ended March 31, 2019 and 2018, respectively. The March 31, 2019 expense was
primarily driven by the accelerated vesting of all outstanding stock option and restricted stock unit grants due to a change
of control clause in the terms of the awards, which was triggered by the sale of our B2B business.
A summary of the activity of the 2007 Plan
and awards issued outside of the 2007 Plan pertaining to stock option grants is as follows:
|
|
Shares Underlying Awards
|
|
|
Weighted Average Exercise Price
|
|
|
Aggregate Intrinsic Value ($000)
|
|
|
Weighted Average Remaining Contractual Life (In Years)
|
|
Awards outstanding at December 31, 2018
|
|
|
371,888
|
|
|
$
|
12.90
|
|
|
|
|
|
|
|
|
|
Options granted
|
|
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
Options exercised
|
|
|
(160,028
|
))
|
|
$
|
12.90
|
|
|
|
|
|
|
|
|
|
Options forfeited
|
|
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
Options expired
|
|
|
(1,462
|
)
|
|
$
|
23.70
|
|
|
|
|
|
|
|
|
|
Awards outstanding at March 31, 2019
|
|
|
210,398
|
|
|
$
|
12.80
|
|
|
$
|
2,204
|
|
|
|
1.71
|
|
Awards outstanding, vested and expected to vest at March 31, 2019
|
|
|
210,398
|
|
|
$
|
12.80
|
|
|
$
|
2,204
|
|
|
|
1.71
|
|
Awards exercisable at March 31, 2019
|
|
|
210,398
|
|
|
$
|
12.80
|
|
|
$
|
2,204
|
|
|
|
1.71
|
|
A summary of the
activity of the 2007 Plan pertaining to grants of restricted stock units is as follows:
|
|
Shares Underlying Awards
|
|
|
Aggregate Intrinsic Value ($000)
|
|
|
Weighted Average Remaining Contractual Life (In Years)
|
|
Awards outstanding at December 31, 2018
|
|
|
284,499
|
|
|
|
|
|
|
|
|
|
Restricted stock units granted
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Restricted stock units settled by delivery of Common Stock upon vesting
|
|
|
(284,499
|
)
|
|
|
|
|
|
|
|
|
Restricted stock units forfeited
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Awards outstanding at March 31, 2019
|
|
|
—
|
|
|
$
|
—
|
|
|
|
—
|
|
Awards expected to vest at March 31, 2019
|
|
|
—
|
|
|
$
|
—
|
|
|
|
—
|
|
A summary of the status of the Company’s
unvested stock-based awards as of March 31, 2019 and changes in the three months then ended is as follows:
Unvested Awards
|
|
Number of Shares
|
|
|
Weighted Average Grant Date Fair Value
|
|
Shares underlying awards unvested at December 31, 2018
|
|
|
345,905
|
|
|
$
|
14.70
|
|
Shares underlying options vested
|
|
|
(61,406
|
)
|
|
$
|
4.00
|
|
Shares underlying restricted stock units settled by delivery of Common Stock upon vesting
|
|
|
(284,499
|
)
|
|
|
17.00
|
|
Shares underlying awards unvested at March 31, 2019
|
|
|
—
|
|
|
$
|
—
|
|
For the three months ended March 31,
2019 and 2018, the total fair value of stock option awards vested was approximately $248 thousand and $109 thousand
respectively. For the three months ended March 31, 2019 and 2018, the total intrinsic value of options exercised was $1.6
million and $0, respectively (there were no options exercised during the three months ended March 31, 2018), yielding $323
thousand of cash proceeds to the Company. For the three months ended March 31, 2019 there were no stock options granted. For
the three months ended March 31, 2018, approximately 300 stock options were granted. For the three months ended March 31,
2019 there were no restricted stock units granted. For the three months ended March 31, 2018, approximately 113 thousand
restricted stock units were granted. For the three months ended March 31, 2019 and 2018, approximately 284 thousand and 900
shares, respectively, were issued under restricted stock unit grants. For the three months ended March 31, 2019 and 2018, the
total intrinsic value of restricted stock units that vested was approximately $6.2 million and $13 thousand respectively. As of
March 31, 2019, the total intrinsic value of awards outstanding was $0. As of March 31, 2018, the total intrinsic value of
awards outstanding was approximately $4.8 million. As of March 31, 2019, there was no unrecognized stock-based compensation
expense remaining to be recognized.
Treasury Stock
In November 2017, our Board of Directors
approved a new share buyback program authorizing the repurchase of up to five million shares of the Company’s Common
Stock (the “Program”). Purchases may be made in the open market or in privately negotiated transactions, subject to
management’s evaluation of the trading price of the security, market conditions and other factors. The Company may, among
other things, utilize existing cash reserves and cash flows from operations to fund any purchases. The timing and amount of any
purchases will be determined by the Company’s management based upon its evaluation. The Program does not obligate the Company
to purchase any dollar amount or number of shares and may be extended, modified, suspended or discontinued at any time. During
the three months ended March 31, 2019, the Company did not purchase any shares of Common Stock under the Program. During the three
months ended March 31, 2018, and since the Program’s inception in November 2017, the Company purchased a total of 111 shares
of Common Stock under the Program at an aggregate cost of approximately $1,415, inclusive of commissions.
In addition, pursuant to the terms of the
Company’s 2007 Plan and certain procedures approved by the Compensation Committee of the Board of Directors, in connection
with the exercise of stock options by certain of the Company’s employees and the issuance of shares of Common Stock in settlement
of vested restricted stock units, the Company may withhold shares in lieu of payment of the exercise price and/or the minimum amount
of applicable withholding taxes then due. During the three months ended March 31, 2019, 188,270 shares were withheld in settlement
of the exercise of stock options and vested restricted stock units. Through March 31, 2019, the Company withheld an aggregate
of 406,153 shares which have been recorded as treasury stock. In addition, the Company received an aggregate of 21,161 shares in
treasury stock resulting from prior acquisitions. These shares have also been recorded as treasury stock.
Dividends
Beginning with the first quarter of
2016, the Company’s Board of Directors suspended the payment of a quarterly dividend and will continue to evaluate the
uses of its cash in connection with planned investments in the business. In April 2019, the Board of Directors approved a
one-time dividend to distribute cash received from the sale of RateWatch, The Deal and BoardEx to the company’s shareholders.
From time to time, the Company may be party
to legal proceedings arising in the ordinary course of business or otherwise. Currently, there are no legal proceedings which are
deemed material.
9.
|
NET INCOME (LOSS) PER SHARE OF COMMON STOCK
|
Basic net income (loss) per share is computed
using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed
using the weighted-average number of common shares and potential common shares outstanding during the period, so long as the inclusion
of potential common shares does not result in a lower net income (loss) per share. Potential common shares consist of unvested
restricted stock units (using the treasury stock method) and the incremental common shares issuable upon the exercise of stock
options (using the treasury stock method). For the three months ended March 31, 2018, approximately 474 thousand unvested restricted
stock units and vested and unvested stock options were excluded from the calculation, as their effect would result in a lower net
loss per share.
The following table reconciles the numerator
and denominator for the calculation.
|
|
For the Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2019
|
|
|
2018
|
|
Basic and diluted net income (loss) per share:
|
|
|
|
|
|
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to common stockholders
|
|
$
|
49,012,664
|
|
|
$
|
(681,710
|
)
|
Denominator:
|
|
|
|
|
|
|
|
|
Weighted average basic shares outstanding
|
|
|
5,095,371
|
|
|
|
4,918,469
|
|
Weighted average diluted shares outstanding
|
|
|
5,242,072
|
|
|
|
4,918,469
|
|
|
|
|
|
|
|
|
|
|
Net loss per share:
|
|
|
|
|
|
|
|
|
Basic net income (loss) attributable to common stockholders
|
|
$
|
9.62
|
|
|
$
|
(0.14
|
)
|
Diluted net income (loss) attributable to common stockholders
|
|
$
|
9.35
|
|
|
$
|
(0.14
|
)
|
The income tax benefit from continuing operations
for the three months ended March 31, 2019 was approximately $2.9 million and reflects an effective tax rate of approximately 36.4%,
as compared to a benefit of approximately $486 thousand for the three months ended March 31, 2018 reflecting an effective tax rate
of approximately 18.2%. The income tax provision for the three months ended March 31, 2019 was prepared on a discrete basis since
for both income tax and financial reporting purposes the Company has elected to change its year end to March 31.
The Company’s effective tax rate (ETR)
for the three months ended March 31, 2019 was primarily impacted by state taxes and the vesting and exercise of shares of common
stock. The Company’s ETR for the three months ended March 31, 2018 was primarily impacted by state taxes and the movement
in the deferred tax liability related to the tax amortization of goodwill. For both years the Company recorded a benefit for the
loss in continuing operations since such current period losses were used to reduce the gain reported in discontinued operations.
Generally, the tax effect of income from continuing operations should be determined without considering the tax effect of items
that are not included in continuing operations. The exception in ASC 740-20-45-7 requires that the gain recorded in discontinued
operations be considered when determining the amount of benefit allocable to continuing operations.
For U.S. income tax purposes, the sale
of BoardEx and The Deal is treated as an asset sale and is primarily offset by net operating losses (“NOLs”) with
the exception of certain state jurisdictions where the Company had insufficient NOLs on hand to fully offset the related tax
incurred. The sale of BoardEx UK and BoardEx India has no tax effect on the Company, as the disposal of these subsidiaries
were treated as a stock sale in their respective foreign jurisdictions. As a result of the sale, the Company utilized $22
million of domestic deferred tax assets of which were primarily attributable to $14.7 million of federal NOLs, $3.2 million
of state NOLs and $3.8M of deferred tax assets related to intangibles and goodwill. In addition, as a result of the disposal
of BoardEx UK and BoardEx India, $1.6 million of foreign deferred tax assets and attributes at December 31, 2018 were removed
from the Company’s balance sheet.
In December 2018, the Company released $16.4
million of valuation allowance based on projected future taxable income which is primarily attributable to the sale of BoardEx
and The Deal on February 13, 2019. During the three months ended March 31, 2019 the Company released valuation allowance of $1.9
million primarily attributable to changes in estimates and information available at the reporting date of the 2018 Form 10K. Specifically,
subsequent to the filing of the 2018 Form 10K, the Company elected to change both their tax and financial reporting years to March
31. As a result, the tax provision for the three months ended March 31, 2019 is recorded discretely and therefore the Company is
no longer able to utilize any losses projected to be generated after March 31, 2019, of which were included in assessing the need
for a valuation allowance as of December 31, 2018. As of March 31, 2019, the Company maintains a full valuation allowance against
the net deferred tax assets as the Company does not believe the realization of such assets is more likely than not as a result
of future projected losses.
The ability of the Company to utilize its
U.S. NOLs in full to reduce future taxable income may become subject to various limitations under Section 382 of the Internal Revenue
Code of 1986 (“IRC”). The utilization of such carryforwards may be limited upon the occurrence of certain ownership
changes, including the purchase and sale of stock by 5% shareholders and the offering of stock by the Company during any three-year
period resulting in an aggregate change of more than 50% of the beneficial ownership of the Company. In the event of an ownership
change, Section 382 imposes an annual limitation on the amount of these carryforwards that can reduce future taxable income. The
Company had previous ownership changes in 2000 and 2007. The annual limitation imposed under the 2000 ownership change expired
in 2013 and the limitation imposed by the 2007 ownership change ended in 2014. Both annual limitations on the ability to utilize
NOL’s has ended.
The Company files U.S. Federal, State and
Foreign tax returns and has determined that its major tax jurisdictions are the United States, India and the United Kingdom. In
most instances, we are no longer subject to federal, state and local income tax examinations by tax authorities for years prior
to 2015 except for India which generally has a longer statute period. The Company is currently not under examination by any federal,
state or local jurisdiction.
The Company recorded an expense of $45
thousand related to state income tax nexus pursuant to ASC 740-10 for the year ended December 31, 2018. The Company did not record
additional expense in March 31, 2019. To the extent these unrecognized tax benefits are ultimately settled, $45 thousand will impact
the Company’s effective tax rate in a future period. The Company does not expect any significant change to the reserve over
the next 12 months.
11.
|
BUSINESS CONCENTRATIONS AND CREDIT RISK
|
Financial instruments that subject the Company
to concentrations of credit risk consist primarily of cash, cash equivalents and restricted cash. The Company maintains all of
its cash, cash equivalents and restricted cash in federally insured financial institutions and performs periodic evaluations of
the relative credit standing of these institutions. As of March 31, 2019 and 2018, the Company’s cash, cash equivalents
and restricted cash primarily consisted of checking accounts and money market funds.
For the three months ended March 31, 2019
and 2018, no individual client accounted for 10% or more of consolidated revenue. As of March 31, 2019, one individual client accounted
for more than 10% of our gross accounts receivable balance. As of December 31, 2018, one individual client accounted for more than
10% of our gross accounts receivable balance.
The Company’s customers are primarily
concentrated in the United States, and we carry accounts receivable balances. The Company performs ongoing credit evaluations,
generally does not require collateral, and establishes an allowance for doubtful accounts based upon factors surrounding the credit
risk of customers, historical trends and other information. To date, actual losses have been within management’s expectations.
12.
|
RESTRUCTURING AND OTHER CHARGES
|
During the three months ended March 31, 2019,
the Company sold its institutional business and incurred restructuring costs as follows:
Severance and benefits
|
|
$
|
1,607,040
|
|
Office abandonment charges
|
|
|
995,989
|
|
Other
|
|
|
298,990
|
|
|
|
$
|
2,902,019
|
|
Included in employee severance and
benefits above is a total of approximately $845 thousand related to our former CEO.
13.
|
OTHER NON-CURRENT LIABILITIES
|
Other non-current liabilities consist
of the following:
|
|
March 31, 2019
|
|
|
December 31, 2018
|
|
Deferred revenue
|
|
$
|
809,240
|
|
|
$
|
865,167
|
|
Deferred rent
|
|
|
—
|
|
|
|
460,401
|
|
Total other liabilities
|
|
$
|
809,240
|
|
|
$
|
1,325,568
|
|
The Company has operating leases primarily
consisting of office space with remaining lease terms of 1 to 2 years, subject to certain renewal options as applicable.
Current leases include our office space in New York, and also amounts for other miscellaneous office equipment.
Leases with an initial term of twelve months
or less are not recorded on the balance sheet, and the Company does not separate lease and nonlease components of contracts. There
are no material residual guarantees associated with any of the Company’s leases, and there are no significant restrictions
or covenants included in the Company’s lease agreements. Certain leases include variable payments related to common area
maintenance and property taxes, which are billed by the landlord, as is customary with these types of charges for office space.
Our lease agreements generally do not provide
an implicit borrowing rate. Therefore, the Company used a benchmark approach to derive an appropriate imputed discount rate. The
Company benchmarked itself against other companies of similar credit ratings and comparable quality and derived an imputed rate,
which was used in a portfolio approach to discount its real estate lease liabilities. We used the incremental borrowing rate on
December 31, 2018 for all leases that commenced prior to that date.
There was no sublease rental income for
the three months ended March 31, 2019, the Company is not the lessor in any lease arrangement, and no related party transactions
for lease arrangements have occurred.
Lease Costs
The table below presents certain information
related to the lease costs for the Company’s operating leases for the three months ended March 31, 2019:
|
|
Three Months Ended
|
|
Components of total lease cost:
|
|
March 31, 2019
|
|
Operating lease expense
|
|
$
|
413,809
|
|
Variable lease cost
|
|
|
80,147
|
|
Total lease cost
|
|
$
|
493,956
|
|
The Company recorded an impairment
charge of $735,900 for the Right Of Use (“ROU”) asset for the New York office space, and also wrote-off $233,140
of fixed assets and leasehold improvements related to the abandonment of a portion of that office space. Further, the Company
abandoned two California office properties and wrote off the ROU assets of about $27 thousand. The impairment charge contemplated an estimate of sub-lease income, however such an arrangement has not yet been executed. The impairment charge
has been included in restructuring expenses as of the period ended March 31, 2019.
Lease Position as of March 31, 2019
Right of use lease assets and lease liabilities
for our operating leases were recorded in the condensed consolidated balance sheet as follows:
|
|
As of
|
|
|
|
March 31, 2019
|
|
Assets
|
|
|
|
|
Lease assets
|
|
$
|
2,228,691
|
|
Impairment
|
|
|
(735,900
|
)
|
Total lease assets
|
|
$
|
1,492,791
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
Current liabilities:
|
|
|
|
|
Lease liability
|
|
$
|
1,732,332
|
|
Noncurrent liabilities:
|
|
|
|
|
Noncurrent lease liability
|
|
|
1,342,235
|
|
Total lease liability
|
|
$
|
3,074,567
|
|
Lease Terms and Discount Rate
The table below presents certain information
related to the weighted average remaining lease term and the weighted average discount rate for the Company’s operating leases
as of March 31, 2019:
Weighted average remaining lease term (in years) – operating leases
|
|
1.74 years
|
|
Weighted average discount rate – operating leases
|
|
|
5.5
|
%
|
Cash Flows
The table below presents certain information
related to the cash flows for the Company’s operating leases for the three months ended March 31, 2019:
|
|
Three Months Ended
|
|
Cash paid for amounts included in the measurement of lease liabilities:
|
|
March 31, 2019
|
|
|
|
|
|
|
Operating cash flows for operating leases
|
|
$
|
505,029
|
|
Supplemental non-cash amounts of lease liabilities arising from obtaining right of use assets
|
|
$
|
5,223,756
|
|
Supplemental non-cash amounts of lease liabilities
transferred in conjunction with sale
|
|
$
|
1,675,735
|
|
Undiscounted Cash Flows
Future lease payments included in the measurement
of lease liabilities on the condensed consolidated balance sheet as of March 31, 2019, for the following five fiscal years and
thereafter were as follows:
|
|
As of
|
|
|
|
March 31, 2019
|
|
2019 - Remaining
|
|
$
|
1,399,970
|
|
2020
|
|
|
1,830,928
|
|
Total future minimum lease payments
|
|
|
3,230,898
|
|
Less effects of discounting
|
|
|
156,331
|
|
Present value of future minimum lease payments
|
|
$
|
3,074,567
|
|
On April 3, 2019, the
Company announced that its Board of Directors had declared a special cash distribution in the amount of approximately $94.3
million or $17.70 per share ($1.77 per share prior to the 10-for-1 reverse stock split effected on April 26, 2019), paid on April
22, 2019 to stockholders of record as of April 15, 2019. In connection with the distribution, the Board of Directors also
approved a 10-for-1 reverse stock split of the Company’s Common Stock effective prior to the opening of trading on
April 26, 2019. Additionally, the Company changed its fiscal and tax year to a March 31 year-end. As such, the
Company’s next fiscal year will run from April 1, 2019 through March 31, 2020. All share amounts and per share amounts
within this Form 10-QT have been adjusted for the 10-for-1 reverse stock split.
16.
|
SEGMENT AND GEOGRAPHIC DATA
|
Segments
Following the sale of RateWatch
in 2018 and our remaining B2B business, comprised of The Deal and BoardEx, in February 2019, we now
report in one segment.
Geographic Data
During the three months ended March 31, 2019
and 2018, substantially all of the Company’s revenue was from customers in the United States and all of our long-lived assets
are located in the United States.